Quantum Biopharma Ltd. Files 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Apr 1, 2026 · CIK: 0001771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Apr 1, 2026 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-issuer, regulatory-filing, press-release
TL;DR
Quantum Biopharma filed a 6-K on 4/1/26, check press release for details.
AI Summary
Quantum Biopharma Ltd. filed a Form 6-K on April 1, 2026, reporting information as a foreign issuer. The filing includes a press release and other documents related to the company's operations. The company's mailing and business address is 55 University Avenue, Suite 1003, Toronto, Ontario, Canada.
Why It Matters
This filing provides updated information for investors and regulatory bodies regarding Quantum Biopharma Ltd.'s status and activities as a foreign issuer.
Risk Assessment
Risk Level: low — A 6-K filing is a routine report for foreign issuers and does not inherently indicate significant risk.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- 0001771885 (company) — CIK Number
- April 1, 2026 (date) — Filing Date
- Toronto, Ontario, Canada (location) — Company Address
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required under Rules 13a-16 and 15d-16, used to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that is made or is required to be made public to any stock exchange on which its securities are traded.
When was this specific Form 6-K filed and accepted by the SEC?
This Form 6-K was filed and accepted by the SEC on April 1, 2026.
What are the included documents in this filing?
The filing includes a FORM 6-K, a PRESS RELEASE (EX-99.1), and a GRAPHIC file (picture1.jpg).
What is Quantum Biopharma Ltd.'s business address?
Quantum Biopharma Ltd.'s business address is 55 University Avenue, Suite 1003, Toronto, Ontario, Canada M5J 2H7.
What is the SIC code for Quantum Biopharma Ltd. and what does it represent?
The SIC code for Quantum Biopharma Ltd. is 2834, which represents Pharmaceutical Preparations. The CF Office is listed as 03 Life Sciences.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.7 · Accepted 2026-04-01 08:02:04
Filing Documents
- f6k_033126.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 16KB
- picture1.jpg (GRAPHIC) — 20KB
- 0001171843-26-002144.txt ( ) — 51KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: April 1, 2026 /s/ Donal Carroll Donal Carroll Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated April 1, 2026